# OnCo record nct05583617 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05583617/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05583617", "NCT05583617" ;
  schema:name "A Study Evaluating the Safety and Efficacy of Multiple Treatments in Participants With Multiple Myeloma"@en ;
  schema:alternateName "PLYCOM"@en ;
  schema:description "A phase 1/2 trial of Cevostamab, Lenalidomide, Tocilizumab in multiple myeloma, run by Hoffmann-La Roche, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05583617/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05583617> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2023-11-14" ;
  onco:cancers <https://onco.cc/cancers/multiple-myeloma/> ;
  onco:drugs <https://onco.cc/drugs/cevostamab/>, <https://onco.cc/drugs/lenalidomide/>, <https://onco.cc/drugs/tocilizumab/>, <https://onco.cc/drugs/iberdomide/>, <https://onco.cc/drugs/dexamethasone/> ;
  onco:companies <https://onco.cc/companies/roche-genentech/> .